designProject Design

Our extensive experience means that we can advise not only on individual protocol development but also whole drug programmes.

This extends from "First in man" and ‘Proof of concept’ trials through to Dose selection designs and other specialist adaptive designs all aimed to extend the speed the development process and increase knowledge of the compound.

We have considerable experience in assimilating and presenting Preclinical pharmacology, Toxicology, Clinical findings as well as Pharmacodynamic and Bio-disposition/Pharmacokinetic information at Regulatory development review meetings.

Our aim is to help clients to make the best possible informed decisions.